TABLE 2

Demographic and disease-related information for focus group participants

Age years65 (52–80)
Sex
 Female7
 Male6
Occupation
 Shop assistant/office worker/factory worker9
 Academic1
 Seaman2
 Self-employed1
Living situation
 Alone3
 With spouse/partner10
Disease
 Small cell lung cancer disseminated disease2
 Nonsmall cell lung cancer stage III–IV5
 COPD GOLD criteria stage IV4
 Idiopathic pulmonary fibrosis2
Treatment
 Inhalation therapy5
 Chemotherapy7
 Immune-modulating therapy3
 Radiation therapy1
Comorbidities
 Asthma, COPD, emphysema, bronchiectases, OSAS9
 Chronic pain, osteoporosis and/or arthrosis7
 Coronary heart disease6
 Diabetes mellitus2
 Dermatological diseases3
 Other malignancies2
 Renal failure2
Medication
 Nonopioid analgesics6
 Opioid analgesics7
 Corticosteroids6
 Benzodiazepines3
 Antiemetics3
 Laxatives4
 Antidiabetics2
 Inhalation aerosol5
 Antihypertensives, statins, diuretics or nitrates4
WHO performance status
 I9
 II3
 III1

Data are presented as mean (range) or n. COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease; OSAS: obstructive sleep apnoea syndrome; WHO: World Health Organization.